Description
Created On: 2020-07-15
Record Count: 7
Primary Industries
- Drugs
- Therapeutic
- Biotechnology
- Disease
- Medical
- Device
- Supply
- Diagnostic
- Technical Know How
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 203051
Certain invention (the Inventions), generally characterized as
1)
UCLA Case No. 1999-560: “NELL-1 Enhanced Bone Mineralizationâ€;
2)
UCLA Case No. 2004-331: “NELL1 Expression Systems and Neuroprotective Activity of NELL2â€;
3)
UCLA Case No. 2006-369: “Recombinant NELL-1 & 2 Protein Productionâ€;
4)
UCLA Case Number: 2009-271: “Recombinant NELL Protein Productionâ€;
5)
UCLA Case No. 2009-569: “NELL-1 Isoformâ€, and
6)
UCLA Case No. 2011-416: “Using NELL-1 to Inhibit Osteoclasts and to Prevent, Treat Osteoporosisâ€
Licensed Product means any article, composition, apparatus, substance, chemical, or any other material whose manufacture, use or sale would constitute an infringement of any Valid Claim within Regents Patent Rights, or any service, article, composition, apparatus, chemical, substance, or any other material made, used, or sold by or utilizing or practicing a Licensed Method. This definition of Licensed Product also includes a service either used by Licensee, an Affiliate, or Sublicensee or provided by Licensee, an Affiliate or Sublicensee to its customers when such service requires the use of Licensed Product or performance of Licensed Method.
Licensed Method means any process or method whose use or practice would constitute an infringement of any Valid Claim within Regents Patent Rights.
Regents Patent Rights:
1999-560-1
NELL-1 Enhanced Bone Mineralization
United States Of America
09/412,297
1999-560-2
NELL -1 Enhanced Bone Mineralization
United States Of America
11/392,294
1999-560-3
Composition for Promoting Cartilage Formation or Repair Comprising a NELL Gene Product and Method of Treating …
United States Of America
11/594,510
1999-560-3
Composition for Promoting Cartilage Formation or Repair Comprising a NELL Gene Product and Method of Treating …
European Patent Office
7871373.2
1999-560-3
Composition for Promoting Cartilage Formation or Repair Comprising a NELL Gene Product and Method of Treating …
Canada
2668375
1999-560-4
NELL-1 Enhanced Bone Mineralization
United States Of America
11/713,366
1999-560-4
NELL-1 Enhanced Bone Mineralization
Canada
2679723
1999-560-6
Composition for Promoting Cartilage Formation or Repair Comprising a NELL Gene Product and Method of Treating …
United States Of America
12/700,644
1999-560-8
NELL-1 Enhanced Bone Mineralization
United States Of America
13/011,736
2004-331-2
NELL Peptide Expression Systems And Bone Formation Activity Of Nell Peptide
United States Of America
10/544,553
2004-331-2
NELL Peptide Expression Systems and Bone Formation Activity of Nell Peptide
United Kingdom
4709500.5
2004-331-2
NELL Peptide Expression Systems and Bone Formation Activity of Nell Peptide
Spain
4709500.5
2004-331-2
NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide
Germany
4709500.5
2004-331-3
Expression System of NELL Peptide
United States Of America
11/601,529
2004-331-3
Expression System of NELL Peptide
European Patent Office
7868700.1
2004-331-7
Expression System of NELL Peptide
United States Of America
12/700,630
2006-369-2
Pharmaceutical Compositions for Treating or Preventing Bone Conditions
United States Of America
11/884,525
2006-369-3
Pharmaceutical Compositions for Treating or Preventing Bone Conditions
United States Of America
12/897,397
2009-271-2
Recombinant NELL Protein Production
United States Of America
13/121,394
2009-271-2
Recombinant NELL Protein Production
United Kingdom
9819839.3
2009-271-2
Recombinant NELL Protein Production
Spain
9819839.3
2009-271-2
Recombinant NELL Protein Production
Germany
9819839.3
2009-271-2
Recombinant NELL Protein Production
France
9819839.3
2009-569-2
Isoform NELL-1 Peptide
United States Of America
13/256,931
2009-569-2
Isoform NELL-1 Peptide
European Patent Office
10756811.5
2009-569-2
Isoform NELL-1 Peptide
Canada
2756168
2009-569-3
Isoform NELL-1 Peptide
United States Of America
15/265,680
IPSCIO Record ID: 266352
Patent No. 8,048,646 from US Application No. 12/400,715 – NELL Peptide Expression Systems And Bone Formation Activity Of Nell Peptide
Patent No. 7,807,787 from US Application No. 12/400,714 – NELL Peptide Expression Systems And Bone Formation Activity Of Nell Peptide
Application No. 09/412,297 – NELL-1 Enhanced Bone Mineralization
Application No. 11/392,294 – NELL -1 Enhanced Bone Mineralization
Application No. 11/713,366 – NELL-1 Enhanced Bone Mineralization
Licensed Product means any article, composition, apparatus, substance, chemical, or any other material whose manufacture, use or sale would constitute an infringement of any Valid Claim within University's Patent Rights, or any service, article, composition, apparatus, chemical, substance, or any other material made, used, or sold by or utilizing or practicing a Licensed Method. This definition of Licensed Product also includes a service either used by Licensee, an Affiliate, or Sublicensee or provided by Licensee, an Affiliate or Sublicensee to its customers when such service requires the use of Licensed Product or performance of Licensed Method.
Licensed Method means any process or method whose use or practice would constitute an infringement of any Valid Claim within University's Patent Rights.
IPSCIO Record ID: 26284
IPSCIO Record ID: 210731
NELL-1’s powerful specific bone and cartilage forming properties are derived from the ability of NELL-1 to only target cells that exhibit an activated “master switch†to develop into bone or cartilage. NELL-1 is a function specific recombinant human protein that has been proven in laboratory bench models to recapitulate normal human growth and development to provide control over bone and cartilage regeneration.
IPSCIO Record ID: 7647
NELL-1 Enhanced Bone Mineralizationâ€â€œNELL-1 Enhanced Bone Mineralizationâ€
“NELL1 Expresion Systems and Neuroprotective Activity of NELL2â€
“Recombinant NELL-1 & 2 Protein Productionâ€
The Licensee manufactures orthobiologic products. The Licensee's protein-based technologies deliver outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
IPSCIO Record ID: 289192
6,589,531 – Recombinant yellow fever virus and method of use thereof
6,893,643 – Recombinant yellow fever virus and methods of use thereof
The term Patent Rights shall also mean, to the extent assigned to or otherwise obtained by The Regents, any reissues, extensions, substitutions, continuations, divisions, and continuation-inpart applications (but excluding those Valid Claims in the continuation-in-part applications that are not supported in the specification of and not entitled to the priority date of the parent application). This definition of Patent Rights excludes any rights in and to New Developments.
Licensed Product(s) means any Product, (which may include, without limitation, a Product for use or used in practicing a Licensed Method and any Product made by practicing a Licensed Method), the manufacture, use, Sale, offer for Sale or import of which, but for the license granted in this Agreement, would infringe, or contribute to, or induce the infringement of, any Patent Rights in any country were they issued at the time of the infringing activity in that country. For the avoidance of doubt, if such Product is a component of a larger unit such as a kit, composition of matter or combination, then such kit, composition of matter or combination is deemed to be the Licensed Product for purposes of this definition.
Product means any kit, article of manufacture, composition of matter, material, compound, component or product.
Licensed Method means any process, art or method the use or practice of which, but for the license granted in this Agreement, would infringe, or contribute to, or induce the infringement of, any Patent Rights in any country were they issued at the time of the infringing activity in that country.
IPSCIO Record ID: 114632
Patent Rights:
Process and compositions for peptide, protein and peptidomimetic synthesis – United States of America Issued (US 6,977,150: Corresponding Appl. No. 10/057,783)
Process and compositions for peptide, protein and peptidomimetic synthesis – Australia Issued (Patent No. 2002255488)
Process and compositions for peptide, protein and peptidomimetic synthesis – Switzerland Issued (Patent No. 1356036; Corresponding Appl. No. 2724888.9)
Process and compositions for peptide, protein and peptidomimetic synthesis – Germany Issued (Patent No. 60226411.1-08; Corresponding Appl. No. 2724888.9)
Process and compositions for peptide, protein and peptidomimetic synthesis – European Patent Office Issued (EP 1 356 036 B1; Corresponding Appl. No. 2724888.9)
Process and compositions for peptide, protein and peptidomimetic synthesis – France Issued (Patent No. 1356036; Corresponding Appl. No. 2724888.9)
Process and compositions for peptide, protein and peptidomimetic synthesis – United Kingdom Issued (Patent No. 1356036; Corresponding Appl. No. 2724888.9)
Process and compositions for peptide, protein and peptidomimetic synthesis – Ireland Issued (Patent No. 1356036; Corresponding Appl. No. 2724888.9)
Pending Applications:
Process and compositions for peptide, protein and peptidomimetic synthesis – Canada Pending Appl. No. 2,435,812
Process and compositions for peptide, protein and peptidomimetic synthesis – Japan Pending Appl. No. 2002-559580